APO Research
Talk to an analyst

APO RESEARCH · REPORT

Small Molecule Innovator CDMO

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Small Molecule Innovator CDMO Industry Growth and Trends Forecast to 2032

29 December 2025106 pages

Choose your research edition.

Industry ResearchSmall Molecule Innovator CDMO Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Small Molecule Innovator CDMO Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Small Molecule Innovator CDMO Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Small Molecule Innovator CDMO Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Small Molecule Innovator CDMO Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Small Molecule Innovator CDMO market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Small Molecule Innovator CDMO is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Small Molecule Innovator CDMO is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Small Molecule Innovator CDMO is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Small Molecule Innovator CDMO include Boehringer Ingelheim, Cambrex Corporation, CATALENT, CordenPharma International, Covance, Piramal Pharma Solutions, Recipharm AB, Siegfried Holding AG and Lonza Group, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Small Molecule Innovator CDMO market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Small Molecule Innovator CDMO market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Small Molecule Innovator CDMO market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Small Molecule Innovator CDMO.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Small Molecule Innovator CDMO market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Small Molecule Innovator CDMO Market by Company

Boehringer Ingelheim

Cambrex Corporation

CATALENT

CordenPharma International

Covance

Piramal Pharma Solutions

Recipharm AB

Siegfried Holding AG

Lonza Group

Thermo Fisher Scientific

Small Molecule Innovator CDMO Segment by Type

Oral Solid Dosage Form

Semi-solid Dosage Form

Small Molecule Innovator CDMO Segment by Application

Pharmaceutical and Biotech Companies

Academic and Research Institutions

Others

Small Molecule Innovator CDMO Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Small Molecule Innovator CDMO market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Small Molecule Innovator CDMO and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Small Molecule Innovator CDMO.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Small Molecule Innovator CDMO manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Small Molecule Innovator CDMO in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Oral Solid Dosage Form Table 2. Major Company of Semi-solid Dosage Form Table 3. Global Small Molecule Innovator CDMO Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Small Molecule Innovator CDMO Sales by Type (2021-2026) & (K Units) Table 5. Global Small Molecule Innovator CDMO Sales Market Share in Volume by Type (2021-2026) Table 6. Global Small Molecule Innovator CDMO Sales by Type (2021-2026) & (US$ Million) Table 7. Global Small Molecule Innovator CDMO Sales Market Share in Value by Type (2021-2026) Table 8. Global Small Molecule Innovator CDMO Price by Type (2021-2026) & (US$/Unit) Table 9. Global Small Molecule Innovator CDMO Sales by Type (2027-2032) & (K Units) Table 10. Global Small Molecule Innovator CDMO Sales Market Share in Volume by Type (2027-2032) Table 11. Global Small Molecule Innovator CDMO Sales by Type (2027-2032) & (US$ Million) Table 12. Global Small Molecule Innovator CDMO Sales Market Share in Value by Type (2027-2032) Table 13. Global Small Molecule Innovator CDMO Price by Type (2027-2032) & (US$/Unit) Table 14. North America Small Molecule Innovator CDMO Sales by Type (2021-2026) & (K Units) Table 15. North America Small Molecule Innovator CDMO Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Small Molecule Innovator CDMO Sales by Type (2021-2026) & (K Units) Table 17. Europe Small Molecule Innovator CDMO Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Small Molecule Innovator CDMO Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Small Molecule Innovator CDMO Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Small Molecule Innovator CDMO Sales by Type (2021-2026) & (K Units) Table 21. Latin America Small Molecule Innovator CDMO Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Small Molecule Innovator CDMO Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Small Molecule Innovator CDMO Sales by Type (2021-2026) & (US$ Million) Table 24. Small Molecule Innovator CDMO Industry Trends Table 25. Small Molecule Innovator CDMO Industry Drivers Table 26. Small Molecule Innovator CDMO Industry Opportunities and Challenges Table 27. Small Molecule Innovator CDMO Industry Restraints Table 28. Global Small Molecule Innovator CDMO Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Small Molecule Innovator CDMO Revenue Market Share by Company (2021-2026) Table 30. Global Small Molecule Innovator CDMO Sales by Company (2021-2026) & (K Units) Table 31. Global Small Molecule Innovator CDMO Sales Share by Company (2021-2026) Table 32. Global Small Molecule Innovator CDMO Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Small Molecule Innovator CDMO Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Small Molecule Innovator CDMO Major Company Production Sites and Headquarters Table 35. Global Small Molecule Innovator CDMO Company, Product Type & Application Table 36. Global Small Molecule Innovator CDMO Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Small Molecule Innovator CDMO by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Small Molecule Innovator CDMO Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Small Molecule Innovator CDMO Sales by Region (2021-2026) & (K Units) Table 41. Global Small Molecule Innovator CDMO Sales Market Share in Volume by Region (2021-2026) Table 42. Global Small Molecule Innovator CDMO Sales by Region (2021-2026) & (US$ Million) Table 43. Global Small Molecule Innovator CDMO Sales Market Share in Value by Region (2021-2026) Table 44. Global Small Molecule Innovator CDMO Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Small Molecule Innovator CDMO Sales by Region (2027-2032) & (K Units) Table 46. Global Small Molecule Innovator CDMO Sales Market Share in Volume by Region (2027-2032) Table 47. Global Small Molecule Innovator CDMO Sales by Region (2027-2032) & (US$ Million) Table 48. Global Small Molecule Innovator CDMO Sales Market Share in Value by Region (2027-2032) Table 49. Global Small Molecule Innovator CDMO Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Small Molecule Innovator CDMO Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Small Molecule Innovator CDMO Sales by Application (2021-2026) & (K Units) Table 52. Global Small Molecule Innovator CDMO Sales Market Share in Volume by Application (2021-2026) Table 53. Global Small Molecule Innovator CDMO Sales by Application (2021-2026) & (US$ Million) Table 54. Global Small Molecule Innovator CDMO Sales Market Share in Value by Application (2021-2026) Table 55. Global Small Molecule Innovator CDMO Price by Application (2021-2026) & (US$/Unit) Table 56. Global Small Molecule Innovator CDMO Sales by Application (2027-2032) & (K Units) Table 57. Global Small Molecule Innovator CDMO Sales Market Share in Volume by Application (2027-2032) Table 58. Global Small Molecule Innovator CDMO Sales by Application (2027-2032) & (US$ Million) Table 59. Global Small Molecule Innovator CDMO Sales Market Share in Value by Application (2027-2032) Table 60. Global Small Molecule Innovator CDMO Price by Application (2027-2032) & (US$/Unit) Table 61. North America Small Molecule Innovator CDMO Sales by Application (2021-2026) & (K Units) Table 62. North America Small Molecule Innovator CDMO Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Small Molecule Innovator CDMO Sales by Application (2021-2026) & (K Units) Table 64. Europe Small Molecule Innovator CDMO Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Small Molecule Innovator CDMO Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Small Molecule Innovator CDMO Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Small Molecule Innovator CDMO Sales by Application (2021-2026) & (K Units) Table 68. Latin America Small Molecule Innovator CDMO Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Small Molecule Innovator CDMO Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Small Molecule Innovator CDMO Sales by Application (2021-2026) & (US$ Million) Table 71. Boehringer Ingelheim Company Information Table 72. Boehringer Ingelheim Business Overview Table 73. Boehringer Ingelheim Small Molecule Innovator CDMO Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Boehringer Ingelheim Small Molecule Innovator CDMO Product Portfolio Table 75. Boehringer Ingelheim Recent Development Table 76. Cambrex Corporation Company Information Table 77. Cambrex Corporation Business Overview Table 78. Cambrex Corporation Small Molecule Innovator CDMO Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Cambrex Corporation Small Molecule Innovator CDMO Product Portfolio Table 80. Cambrex Corporation Recent Development Table 81. CATALENT Company Information Table 82. CATALENT Business Overview Table 83. CATALENT Small Molecule Innovator CDMO Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. CATALENT Small Molecule Innovator CDMO Product Portfolio Table 85. CATALENT Recent Development Table 86. CordenPharma International Company Information Table 87. CordenPharma International Business Overview Table 88. CordenPharma International Small Molecule Innovator CDMO Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. CordenPharma International Small Molecule Innovator CDMO Product Portfolio Table 90. CordenPharma International Recent Development Table 91. Covance Company Information Table 92. Covance Business Overview Table 93. Covance Small Molecule Innovator CDMO Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Covance Small Molecule Innovator CDMO Product Portfolio Table 95. Covance Recent Development Table 96. Piramal Pharma Solutions Company Information Table 97. Piramal Pharma Solutions Business Overview Table 98. Piramal Pharma Solutions Small Molecule Innovator CDMO Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Piramal Pharma Solutions Small Molecule Innovator CDMO Product Portfolio Table 100. Piramal Pharma Solutions Recent Development Table 101. Recipharm AB Company Information Table 102. Recipharm AB Business Overview Table 103. Recipharm AB Small Molecule Innovator CDMO Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Recipharm AB Small Molecule Innovator CDMO Product Portfolio Table 105. Recipharm AB Recent Development Table 106. Siegfried Holding AG Company Information Table 107. Siegfried Holding AG Business Overview Table 108. Siegfried Holding AG Small Molecule Innovator CDMO Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Siegfried Holding AG Small Molecule Innovator CDMO Product Portfolio Table 110. Siegfried Holding AG Recent Development Table 111. Lonza Group Company Information Table 112. Lonza Group Business Overview Table 113. Lonza Group Small Molecule Innovator CDMO Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Lonza Group Small Molecule Innovator CDMO Product Portfolio Table 115. Lonza Group Recent Development Table 116. Thermo Fisher Scientific Company Information Table 117. Thermo Fisher Scientific Business Overview Table 118. Thermo Fisher Scientific Small Molecule Innovator CDMO Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Thermo Fisher Scientific Small Molecule Innovator CDMO Product Portfolio Table 120. Thermo Fisher Scientific Recent Development Table 121. North America Small Molecule Innovator CDMO Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 122. North America Small Molecule Innovator CDMO Sales by Country (2021-2026) & (K Units) Table 123. North America Small Molecule Innovator CDMO Sales Market Share by Country (2021-2026) Table 124. North America Small Molecule Innovator CDMO Sales Forecast by Country (2027-2032) & (K Units) Table 125. North America Small Molecule Innovator CDMO Sales Market Share Forecast by Country (2027-2032) Table 126. North America Small Molecule Innovator CDMO Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. North America Small Molecule Innovator CDMO Market Size by Country (2021-2026) & (US$ Million) Table 128. North America Small Molecule Innovator CDMO Market Share by Country (2021-2026) Table 129. North America Small Molecule Innovator CDMO Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. North America Small Molecule Innovator CDMO Market Share Forecast by Country (2027-2032) Table 131. Europe Small Molecule Innovator CDMO Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 132. Europe Small Molecule Innovator CDMO Sales by Country (2021-2026) & (K Units) Table 133. Europe Small Molecule Innovator CDMO Sales Market Share by Country (2021-2026) Table 134. Europe Small Molecule Innovator CDMO Sales Forecast by Country (2027-2032) & (K Units) Table 135. Europe Small Molecule Innovator CDMO Sales Market Share Forecast by Country (2027-2032) Table 136. Europe Small Molecule Innovator CDMO Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Europe Small Molecule Innovator CDMO Market Size by Country (2021-2026) & (US$ Million) Table 138. Europe Small Molecule Innovator CDMO Market Share by Country (2021-2026) Table 139. Europe Small Molecule Innovator CDMO Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Europe Small Molecule Innovator CDMO Market Share Forecast by Country (2027-2032) Table 141. Asia-Pacific Small Molecule Innovator CDMO Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 142. Asia-Pacific Small Molecule Innovator CDMO Sales by Country (2021-2026) & (K Units) Table 143. Asia-Pacific Small Molecule Innovator CDMO Sales Market Share by Country (2021-2026) Table 144. Asia-Pacific Small Molecule Innovator CDMO Sales Forecast by Country (2027-2032) & (K Units) Table 145. Asia-Pacific Small Molecule Innovator CDMO Sales Market Share Forecast by Country (2027-2032) Table 146. Asia-Pacific Small Molecule Innovator CDMO Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Asia-Pacific Small Molecule Innovator CDMO Market Size by Country (2021-2026) & (US$ Million) Table 148. Asia-Pacific Small Molecule Innovator CDMO Market Share by Country (2021-2026) Table 149. Asia-Pacific Small Molecule Innovator CDMO Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Asia-Pacific Small Molecule Innovator CDMO Market Share Forecast by Country (2027-2032) Table 151. Latin America Small Molecule Innovator CDMO Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 152. Latin America Small Molecule Innovator CDMO Sales by Country (2021-2026) & (K Units) Table 153. Latin America Small Molecule Innovator CDMO Sales Market Share by Country (2021-2026) Table 154. Latin America Small Molecule Innovator CDMO Sales Forecast by Country (2027-2032) & (K Units) Table 155. Latin America Small Molecule Innovator CDMO Sales Market Share Forecast by Country (2027-2032) Table 156. Latin America Small Molecule Innovator CDMO Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Latin America Small Molecule Innovator CDMO Market Size by Country (2021-2026) & (US$ Million) Table 158. Latin America Small Molecule Innovator CDMO Market Share by Country (2021-2026) Table 159. Latin America Small Molecule Innovator CDMO Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Latin America Small Molecule Innovator CDMO Market Share Forecast by Country (2027-2032) Table 161. Middle East and Africa Small Molecule Innovator CDMO Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 162. Middle East and Africa Small Molecule Innovator CDMO Sales by Country (2021-2026) & (K Units) Table 163. Middle East and Africa Small Molecule Innovator CDMO Sales Market Share by Country (2021-2026) Table 164. Middle East and Africa Small Molecule Innovator CDMO Sales Forecast by Country (2027-2032) & (K Units) Table 165. Middle East and Africa Small Molecule Innovator CDMO Sales Market Share Forecast by Country (2027-2032) Table 166. Middle East and Africa Small Molecule Innovator CDMO Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Middle East and Africa Small Molecule Innovator CDMO Market Size by Country (2021-2026) & (US$ Million) Table 168. Middle East and Africa Small Molecule Innovator CDMO Market Share by Country (2021-2026) Table 169. Middle East and Africa Small Molecule Innovator CDMO Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Middle East and Africa Small Molecule Innovator CDMO Market Share Forecast by Country (2027-2032) Table 171. Key Raw Materials Table 172. Raw Materials Key Suppliers Table 173. Small Molecule Innovator CDMO Distributors List Table 174. Small Molecule Innovator CDMO Customers List Table 175. Research Programs/Design for This Report Table 176. Authors List of This Report Table 177. Secondary Sources Table 178. Primary Sources List of Figures Figure 1. Small Molecule Innovator CDMO Image Figure 2. Global Small Molecule Innovator CDMO Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Small Molecule Innovator CDMO Market Size (2021-2032) & (US$ Million) Figure 4. Global Small Molecule Innovator CDMO Sales (2021-2032) & (K Units) Figure 5. Oral Solid Dosage Form Image Figure 6. Global Oral Solid Dosage Form Sales YoY Growth (2021-2032) & (K Units) Figure 7. Semi-solid Dosage Form Image Figure 8. Global Semi-solid Dosage Form Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Small Molecule Innovator CDMO Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Small Molecule Innovator CDMO Market Share by Type 2025 VS 2032 Figure 11. North America Small Molecule Innovator CDMO Sales Market Share in Volume by Type in 2025 Figure 12. North America Small Molecule Innovator CDMO Sales Market Share in Value by Type in 2025 Figure 13. Europe Small Molecule Innovator CDMO Sales Market Share in Volume by Type in 2025 Figure 14. Europe Small Molecule Innovator CDMO Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Small Molecule Innovator CDMO Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Small Molecule Innovator CDMO Sales Market Share in Value by Type in 2025 Figure 17. Latin America Small Molecule Innovator CDMO Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Small Molecule Innovator CDMO Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Small Molecule Innovator CDMO Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Small Molecule Innovator CDMO Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Small Molecule Innovator CDMO Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Pharmaceutical and Biotech Companies Image Figure 24. Global Pharmaceutical and Biotech Companies Sales YoY Growth (2021-2032) & (K Units) Figure 25. Academic and Research Institutions Image Figure 26. Global Academic and Research Institutions Sales YoY Growth (2021-2032) & (K Units) Figure 27. Others Image Figure 28. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Small Molecule Innovator CDMO Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Small Molecule Innovator CDMO Market Share by Application 2025 VS 2032 Figure 31. North America Small Molecule Innovator CDMO Sales Market Share in Volume by Application in 2025 Figure 32. North America Small Molecule Innovator CDMO Sales Market Share in Value by Application in 2025 Figure 33. Europe Small Molecule Innovator CDMO Sales Market Share in Volume by Application in 2025 Figure 34. Europe Small Molecule Innovator CDMO Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Small Molecule Innovator CDMO Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Small Molecule Innovator CDMO Sales Market Share in Value by Application in 2025 Figure 37. Latin America Small Molecule Innovator CDMO Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Small Molecule Innovator CDMO Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Small Molecule Innovator CDMO Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Small Molecule Innovator CDMO Sales Market Share in Value by Application in 2025 Figure 41. North America Small Molecule Innovator CDMO Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Small Molecule Innovator CDMO Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Small Molecule Innovator CDMO Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Small Molecule Innovator CDMO Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Small Molecule Innovator CDMO Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Small Molecule Innovator CDMO Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Small Molecule Innovator CDMO Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Small Molecule Innovator CDMO Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Small Molecule Innovator CDMO Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Small Molecule Innovator CDMO Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Small Molecule Innovator CDMO Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Small Molecule Innovator CDMO Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Small Molecule Innovator CDMO Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Small Molecule Innovator CDMO Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Small Molecule Innovator CDMO Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Small Molecule Innovator CDMO Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Small Molecule Innovator CDMO Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Small Molecule Innovator CDMO Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Small Molecule Innovator CDMO Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Small Molecule Innovator CDMO Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Small Molecule Innovator CDMO Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Small Molecule Innovator CDMO Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Oral Solid Dosage Form
  • Semi-solid Dosage Form
Applications
  • Pharmaceutical and Biotech Companies
  • Academic and Research Institutions
  • Others
Companies covered
  • Boehringer Ingelheim
  • Cambrex Corporation
  • CATALENT
  • CordenPharma International
  • Covance
  • Piramal Pharma Solutions
  • Recipharm AB
  • Siegfried Holding AG
  • Lonza Group
  • Thermo Fisher Scientific

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Small Molecule Innovator CDMO Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Small Molecule Innovator CDMO Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Small Molecule Innovator CDMO Market by Type
  6. 1.3.1 Oral Solid Dosage Form
  7. 1.3.2 Semi-solid Dosage Form
  8. 1.4 Global Small Molecule Innovator CDMO Market Size by Type
  9. 1.4.1 Global Small Molecule Innovator CDMO Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Small Molecule Innovator CDMO Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Small Molecule Innovator CDMO Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Small Molecule Innovator CDMO Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Small Molecule Innovator CDMO Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Small Molecule Innovator CDMO Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Small Molecule Innovator CDMO Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Small Molecule Innovator CDMO Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Small Molecule Innovator CDMO Industry Trends
  2. 2.2 Small Molecule Innovator CDMO Industry Drivers
  3. 2.3 Small Molecule Innovator CDMO Industry Opportunities and Challenges
  4. 2.4 Small Molecule Innovator CDMO Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Small Molecule Innovator CDMO Revenue (2021-2026)
  2. 3.2 Global Top Players by Small Molecule Innovator CDMO Sales (2021-2026)
  3. 3.3 Global Top Players by Small Molecule Innovator CDMO Price (2021-2026)
  4. 3.4 Global Small Molecule Innovator CDMO Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Small Molecule Innovator CDMO Major Company Production Sites & Headquarters
  6. 3.6 Global Small Molecule Innovator CDMO Company, Product Type & Application
  7. 3.7 Global Small Molecule Innovator CDMO Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Small Molecule Innovator CDMO Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Small Molecule Innovator CDMO Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Small Molecule Innovator CDMO Tier 1, Tier 2, and Tier 3
4 Small Molecule Innovator CDMO Regional Status and Outlook
  1. 4.1 Global Small Molecule Innovator CDMO Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Small Molecule Innovator CDMO Historic Market Size by Region
  3. 4.2.1 Global Small Molecule Innovator CDMO Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Small Molecule Innovator CDMO Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Small Molecule Innovator CDMO Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Small Molecule Innovator CDMO Forecasted Market Size by Region
  7. 4.3.1 Global Small Molecule Innovator CDMO Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Small Molecule Innovator CDMO Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Small Molecule Innovator CDMO Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Small Molecule Innovator CDMO by Application
  1. 5.1 Small Molecule Innovator CDMO Market by Application
  2. 5.1.1 Pharmaceutical and Biotech Companies
  3. 5.1.2 Academic and Research Institutions
  4. 5.1.3 Others
  5. 5.2 Global Small Molecule Innovator CDMO Market Size by Application
  6. 5.2.1 Global Small Molecule Innovator CDMO Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Small Molecule Innovator CDMO Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Small Molecule Innovator CDMO Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Small Molecule Innovator CDMO Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Small Molecule Innovator CDMO Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Small Molecule Innovator CDMO Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Small Molecule Innovator CDMO Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Small Molecule Innovator CDMO Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Boehringer Ingelheim
  2. 6.1.1 Boehringer Ingelheim Company Information
  3. 6.1.2 Boehringer Ingelheim Business Overview
  4. 6.1.3 Boehringer Ingelheim Small Molecule Innovator CDMO Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Boehringer Ingelheim Small Molecule Innovator CDMO Product Portfolio
  6. 6.1.5 Boehringer Ingelheim Recent Developments
  7. 6.2 Cambrex Corporation
  8. 6.2.1 Cambrex Corporation Company Information
  9. 6.2.2 Cambrex Corporation Business Overview
  10. 6.2.3 Cambrex Corporation Small Molecule Innovator CDMO Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Cambrex Corporation Small Molecule Innovator CDMO Product Portfolio
  12. 6.2.5 Cambrex Corporation Recent Developments
  13. 6.3 CATALENT
  14. 6.3.1 CATALENT Company Information
  15. 6.3.2 CATALENT Business Overview
  16. 6.3.3 CATALENT Small Molecule Innovator CDMO Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 CATALENT Small Molecule Innovator CDMO Product Portfolio
  18. 6.3.5 CATALENT Recent Developments
  19. 6.4 CordenPharma International
  20. 6.4.1 CordenPharma International Company Information
  21. 6.4.2 CordenPharma International Business Overview
  22. 6.4.3 CordenPharma International Small Molecule Innovator CDMO Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 CordenPharma International Small Molecule Innovator CDMO Product Portfolio
  24. 6.4.5 CordenPharma International Recent Developments
  25. 6.5 Covance
  26. 6.5.1 Covance Company Information
  27. 6.5.2 Covance Business Overview
  28. 6.5.3 Covance Small Molecule Innovator CDMO Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Covance Small Molecule Innovator CDMO Product Portfolio
  30. 6.5.5 Covance Recent Developments
  31. 6.6 Piramal Pharma Solutions
  32. 6.6.1 Piramal Pharma Solutions Company Information
  33. 6.6.2 Piramal Pharma Solutions Business Overview
  34. 6.6.3 Piramal Pharma Solutions Small Molecule Innovator CDMO Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Piramal Pharma Solutions Small Molecule Innovator CDMO Product Portfolio
  36. 6.6.5 Piramal Pharma Solutions Recent Developments
  37. 6.7 Recipharm AB
  38. 6.7.1 Recipharm AB Company Information
  39. 6.7.2 Recipharm AB Business Overview
  40. 6.7.3 Recipharm AB Small Molecule Innovator CDMO Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Recipharm AB Small Molecule Innovator CDMO Product Portfolio
  42. 6.7.5 Recipharm AB Recent Developments
  43. 6.8 Siegfried Holding AG
  44. 6.8.1 Siegfried Holding AG Company Information
  45. 6.8.2 Siegfried Holding AG Business Overview
  46. 6.8.3 Siegfried Holding AG Small Molecule Innovator CDMO Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Siegfried Holding AG Small Molecule Innovator CDMO Product Portfolio
  48. 6.8.5 Siegfried Holding AG Recent Developments
  49. 6.9 Lonza Group
  50. 6.9.1 Lonza Group Company Information
  51. 6.9.2 Lonza Group Business Overview
  52. 6.9.3 Lonza Group Small Molecule Innovator CDMO Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Lonza Group Small Molecule Innovator CDMO Product Portfolio
  54. 6.9.5 Lonza Group Recent Developments
  55. 6.10 Thermo Fisher Scientific
  56. 6.10.1 Thermo Fisher Scientific Company Information
  57. 6.10.2 Thermo Fisher Scientific Business Overview
  58. 6.10.3 Thermo Fisher Scientific Small Molecule Innovator CDMO Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Thermo Fisher Scientific Small Molecule Innovator CDMO Product Portfolio
  60. 6.10.5 Thermo Fisher Scientific Recent Developments
7 North America by Country
  1. 7.1 North America Small Molecule Innovator CDMO Sales by Country
  2. 7.1.1 North America Small Molecule Innovator CDMO Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Small Molecule Innovator CDMO Sales by Country (2021-2026)
  4. 7.1.3 North America Small Molecule Innovator CDMO Sales Forecast by Country (2027-2032)
  5. 7.2 North America Small Molecule Innovator CDMO Market Size by Country
  6. 7.2.1 North America Small Molecule Innovator CDMO Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Small Molecule Innovator CDMO Market Size by Country (2021-2026)
  8. 7.2.3 North America Small Molecule Innovator CDMO Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Small Molecule Innovator CDMO Sales by Country
  2. 8.1.1 Europe Small Molecule Innovator CDMO Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Small Molecule Innovator CDMO Sales by Country (2021-2026)
  4. 8.1.3 Europe Small Molecule Innovator CDMO Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Small Molecule Innovator CDMO Market Size by Country
  6. 8.2.1 Europe Small Molecule Innovator CDMO Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Small Molecule Innovator CDMO Market Size by Country (2021-2026)
  8. 8.2.3 Europe Small Molecule Innovator CDMO Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Small Molecule Innovator CDMO Sales by Country
  2. 9.1.1 Asia-Pacific Small Molecule Innovator CDMO Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Small Molecule Innovator CDMO Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Small Molecule Innovator CDMO Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Small Molecule Innovator CDMO Market Size by Country
  6. 9.2.1 Asia-Pacific Small Molecule Innovator CDMO Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Small Molecule Innovator CDMO Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Small Molecule Innovator CDMO Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Small Molecule Innovator CDMO Sales by Country
  2. 10.1.1 South America Small Molecule Innovator CDMO Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Small Molecule Innovator CDMO Sales by Country (2021-2026)
  4. 10.1.3 South America Small Molecule Innovator CDMO Sales Forecast by Country (2027-2032)
  5. 10.2 South America Small Molecule Innovator CDMO Market Size by Country
  6. 10.2.1 South America Small Molecule Innovator CDMO Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Small Molecule Innovator CDMO Market Size by Country (2021-2026)
  8. 10.2.3 South America Small Molecule Innovator CDMO Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Small Molecule Innovator CDMO Sales by Country
  2. 11.1.1 Middle East and Africa Small Molecule Innovator CDMO Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Small Molecule Innovator CDMO Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Small Molecule Innovator CDMO Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Small Molecule Innovator CDMO Market Size by Country
  6. 11.2.1 Middle East and Africa Small Molecule Innovator CDMO Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Small Molecule Innovator CDMO Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Small Molecule Innovator CDMO Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Small Molecule Innovator CDMO Value Chain Analysis
  2. 12.1.1 Small Molecule Innovator CDMO Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Small Molecule Innovator CDMO Production Mode & Process
  7. 12.2 Small Molecule Innovator CDMO Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Small Molecule Innovator CDMO Distributors
  10. 12.2.3 Small Molecule Innovator CDMO Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst